285 related articles for article (PubMed ID: 37508575)
21. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
Front Immunol; 2020; 11():613215. PubMed ID: 33679700
[TBL] [Abstract][Full Text] [Related]
22. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
23. MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.
Liu H; Wang Z; Zhou Y; Yang Y
Front Immunol; 2023; 14():1199273. PubMed ID: 37465670
[TBL] [Abstract][Full Text] [Related]
24. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.
Joshi S; Sharabi A
Pharmacol Ther; 2022 Jul; 235():108114. PubMed ID: 35122833
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
26. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
Yin Z; Li C; Wang J; Xue L
Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
[TBL] [Abstract][Full Text] [Related]
27. (3R)-5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one enhanced the therapeutic efficacy of anti-PD1 antibody through inhibiting PI3Kδ/γ.
Cao L; Dai C; Qin R; Guo Y; Liu J
Immunopharmacol Immunotoxicol; 2019 Dec; 41(6):599-606. PubMed ID: 31691624
[No Abstract] [Full Text] [Related]
28. The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.
Shokati E; Safari E
Int Immunopharmacol; 2023 Jul; 120():110267. PubMed ID: 37276829
[TBL] [Abstract][Full Text] [Related]
29. Suppression of T cells by myeloid-derived suppressor cells in cancer.
Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives.
Mortezaee K
Life Sci; 2021 Jul; 277():119627. PubMed ID: 34004256
[TBL] [Abstract][Full Text] [Related]
31. [The role of myeloid-derived suppressor cells in glioma microenvironment].
Gao C; Wang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Jun; 36(3):515-520. PubMed ID: 31232558
[TBL] [Abstract][Full Text] [Related]
32. TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression.
Cao P; Sun Z; Zhang F; Zhang J; Zheng X; Yu B; Zhao Y; Wang W; Wang W
Front Immunol; 2022; 13():919674. PubMed ID: 35874674
[TBL] [Abstract][Full Text] [Related]
33. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.
Chen Z; Yuan R; Hu S; Yuan W; Sun Z
Front Immunol; 2022; 13():817942. PubMed ID: 35154134
[TBL] [Abstract][Full Text] [Related]
34. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
35. Myeloid-Derived Suppressor Cells in Solid Tumors.
Ma T; Renz BW; Ilmer M; Koch D; Yang Y; Werner J; Bazhin AV
Cells; 2022 Jan; 11(2):. PubMed ID: 35053426
[TBL] [Abstract][Full Text] [Related]
36. Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells.
Tian X; Wang T; Shen H; Wang S
Cytokine Growth Factor Rev; 2023 Dec; 74():108-121. PubMed ID: 37598011
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
38. Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products.
Calderon JJ; Prieto K; Lasso P; Fiorentino S; Barreto A
Arch Immunol Ther Exp (Warsz); 2023 Jul; 71(1):17. PubMed ID: 37410164
[TBL] [Abstract][Full Text] [Related]
39. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.
Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q
Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937
[TBL] [Abstract][Full Text] [Related]
40. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]